Industry: Medical Devices & Consumables
Published Date: 2025-05-24
Pages: 96 Pages
Report ld: 4744510
Request Sample
Customized Report
Animal Models Used in Tests Market Size(US$)

CAGR 2025-2031
5.4%
Market Size,2031
USD 3,763
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
The global Animal Models Used in Tests market size was US$ 2617 million in 2024 and is forecast to a readjusted size of US$ 3763 million by 2031 with a CAGR of 5.4% during the forecast period 2025-2031.
Animal model is a living, non-human animal used during the research and investigation of human disease, for the purpose of better understanding the disease without the added risk of harming an actual human being during the process. Animal models have been used to address a variety of scientific questions, from basic science to the development and assessment of novel vaccines, or therapies. The use of animals is not only based on the vast commonalities in the biology of most mammals, but also on the fact that human diseases often affect other animal species. It is particularly the case for most infectious diseases but also for very common conditions such as Type I diabetes, hypertension, allergies, cancer, epilepsy, myopathies and so on. Not only are these diseases shared but the mechanisms are often also so similar that 90% of the veterinary drugs used to treat animals are identical or very similar to those used to treat humans. In our report, all the animals used in scientific purposes are included.
The Animal Models Used in Tests market is driven by the growing need for reliable and reproducible preclinical data in drug discovery, toxicology studies, and biomedical research. Animal models play a critical role in understanding disease mechanisms, evaluating therapeutic efficacy, and ensuring safety before human trials. The increasing prevalence of chronic and genetic diseases, coupled with the rise in R&D activities by pharmaceutical and biotechnology companies, is fueling the demand for advanced and genetically modified animal models. Additionally, government funding and academic support for translational research are further propelling market growth, especially in areas like oncology, neurology, and infectious diseases.
Despite their importance, the use of animal models in testing faces several challenges, including ethical concerns, high costs, and limitations in accurately mimicking human biology. Regulatory pressures and growing advocacy for animal welfare have led to stricter guidelines and increased demand for alternatives such as organ-on-a-chip and computer-based simulations. Furthermore, the development and maintenance of genetically modified or disease-specific models require significant investment and specialized facilities. The reproducibility crisis in biomedical research, partly due to variability in animal studies, also threatens scientific credibility. Overcoming these issues requires ethical oversight, technological innovation, and balanced integration of alternative methods.
The global Animal Models Used in Tests market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on revenue and forecasts across regions, by Type, and by Application for 2020-2031.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Report scope, executive summary, and market evolution scenarios (short/mid/long term).
Chapter 2: Quantitative analysis of Animal Models Used in Tests market size and growth potential at global, regional, and country levels.
Chapter 3: Competitive benchmarking of manufacturers (revenue, market share, M&A, R&D focus).
Chapter 4: Type-based segmentation analysis – Uncovering blue ocean markets (e.g., Mice in China).
Chapter 5: Application-based segmentation analysis – High-growth downstream opportunities (e.g., Pharmaceutical & Biotechnology Companies in India).
Chapter 6: Regional revenue breakdown by company, type, application and customer.
Chapter 7: Key manufacturer profiles – Financials, product portfolios, and strategic developments.
Chapter 8: Market dynamics – Drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 9: Actionable conclusions and strategic recommendations.
WHY THIS REPORT
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Animal Models Used in Tests value chain, addressing:
- Market entry risks/opportunities by region
- Product mix optimization based on local practices
- Competitor tactics in fragmented vs. consolidated markets
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Report Overview
1.1 Study Scope
1.2 Market by Type
1.2.1 Global Market Size Growth by Type: 2020 VS 2024 VS 2031
1.2.2 Rats
1.2.3 Mice
1.2.4 Others
1.3 Market by Application
1.3.1 Global Market Share by Application: 2020 VS 2024 VS 2031
1.3.2 Academic & Research Institutes
1.3.3 Pharmaceutical & Biotechnology Companies
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Animal Models Used in Tests Market Perspective (2020-2031)
2.2 Global Market Size by Region: 2020 VS 2024 VS 2031
2.3 Global Animal Models Used in Tests Revenue Market Share by Region (2020-2025)
2.4 Global Animal Models Used in Tests Revenue Forecast by Region (2026-2031)
2.5 Major Region and Emerging Market Analysis
2.5.1 North America Animal Models Used in Tests Market Size and Prospective (2020-2031)
2.5.2 Europe Animal Models Used in Tests Market Size and Prospective (2020-2031)
2.5.3 Asia-Pacific Animal Models Used in Tests Market Size and Prospective (2020-2031)
2.5.4 Latin America Animal Models Used in Tests Market Size and Prospective (2020-2031)
2.5.5 Middle East & Africa Animal Models Used in Tests Market Size and Prospective (2020-2031)
3 Breakdown Data by Type
3.1 Global Animal Models Used in Tests Historic Market Size by Type (2020-2025)
3.2 Global Animal Models Used in Tests Forecasted Market Size by Type (2026-2031)
3.3 Different Types Animal Models Used in Tests Representative Players
4 Breakdown Data by Application
4.1 Global Animal Models Used in Tests Historic Market Size by Application (2020-2025)
4.2 Global Animal Models Used in Tests Forecasted Market Size by Application (2026-2031)
4.3 New Sources of Growth in Animal Models Used in Tests Application
5 Competition Landscape by Players
5.1 Global Top Players by Revenue
5.1.1 Global Top Animal Models Used in Tests Players by Revenue (2020-2025)
5.1.2 Global Animal Models Used in Tests Revenue Market Share by Players (2020-2025)
5.2 Global Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
5.3 Players Covered: Ranking by Animal Models Used in Tests Revenue
5.4 Global Animal Models Used in Tests Market Concentration Analysis
5.4.1 Global Animal Models Used in Tests Market Concentration Ratio (CR5 and HHI)
5.4.2 Global Top 10 and Top 5 Companies by Animal Models Used in Tests Revenue in 2024
5.5 Global Key Players of Animal Models Used in Tests Head office and Area Served
5.6 Global Key Players of Animal Models Used in Tests, Product and Application
5.7 Global Key Players of Animal Models Used in Tests, Date of Enter into This Industry
5.8 Mergers & Acquisitions, Expansion Plans
6 Region Analysis
6.1 North America Market: Players, Segments and Downstream
6.1.1 North America Animal Models Used in Tests Revenue by Company (2020-2025)
6.1.2 North America Market Size by Type
6.1.2.1 North America Animal Models Used in Tests Market Size by Type (2020-2025)
6.1.2.2 North America Animal Models Used in Tests Market Share by Type (2020-2025)
6.1.3 North America Market Size by Application
6.1.3.1 North America Animal Models Used in Tests Market Size by Application (2020-2025)
6.1.3.2 North America Animal Models Used in Tests Market Share by Application (2020-2025)
6.1.4 North America Market Trend and Opportunities
6.2 Europe Market: Players, Segments and Downstream
6.2.1 Europe Animal Models Used in Tests Revenue by Company (2020-2025)
6.2.2 Europe Market Size by Type
6.2.2.1 Europe Animal Models Used in Tests Market Size by Type (2020-2025)
6.2.2.2 Europe Animal Models Used in Tests Market Share by Type (2020-2025)
6.2.3 Europe Market Size by Application
6.2.3.1 Europe Animal Models Used in Tests Market Size by Application (2020-2025)
6.2.3.2 Europe Animal Models Used in Tests Market Share by Application (2020-2025)
6.2.4 Europe Market Trend and Opportunities
6.3 Asia-Pacific Market: Players, Segments and Downstream
6.3.1 Asia-Pacific Animal Models Used in Tests Revenue by Company (2020-2025)
6.3.2 Asia-Pacific Market Size by Type
6.3.2.1 Asia-Pacific Animal Models Used in Tests Market Size by Type (2020-2025)
6.3.2.2 Asia-Pacific Animal Models Used in Tests Market Share by Type (2020-2025)
6.3.3 Asia-Pacific Market Size by Application
6.3.3.1 Asia-Pacific Animal Models Used in Tests Market Size by Application (2020-2025)
6.3.3.2 Asia-Pacific Animal Models Used in Tests Market Share by Application (2020-2025)
6.3.4 Asia-Pacific Market Trend and Opportunities
6.4 Latin America Market: Players, Segments and Downstream
6.4.1 Latin America Animal Models Used in Tests Revenue by Company (2020-2025)
6.4.2 Latin America Market Size by Type
6.4.2.1 Latin America Animal Models Used in Tests Market Size by Type (2020-2025)
6.4.2.2 Latin America Animal Models Used in Tests Market Share by Type (2020-2025)
6.4.3 Latin America Market Size by Application
6.4.3.1 Latin America Animal Models Used in Tests Market Size by Application (2020-2025)
6.4.3.2 Latin America Animal Models Used in Tests Market Share by Application (2020-2025)
6.4.4 Latin America Market Trend and Opportunities
6.5 Middle East & Africa Market: Players, Segments and Downstream
6.5.1 Middle East & Africa Animal Models Used in Tests Revenue by Company (2020-2025)
6.5.2 Middle East & Africa Market Size by Type
6.5.2.1 Middle East & Africa Animal Models Used in Tests Market Size by Type (2020-2025)
6.5.2.2 Middle East & Africa Animal Models Used in Tests Market Share by Type (2020-2025)
6.5.3 Middle East & Africa Market Size by Application
6.5.3.1 Middle East & Africa Animal Models Used in Tests Market Size by Application (2020-2025)
6.5.3.2 Middle East & Africa Animal Models Used in Tests Market Share by Application (2020-2025)
6.5.4 Middle East & Africa Market Trend and Opportunities
7 Key Players Profiles
7.1 Charles River Laboratories
7.1.1 Charles River Laboratories Company Details
7.1.2 Charles River Laboratories Business Overview
7.1.3 Charles River Laboratories Animal Models Used in Tests Introduction
7.1.4 Charles River Laboratories Revenue in Animal Models Used in Tests Business (2020-2025)
7.1.5 Charles River Laboratories Recent Development
7.2 Envigo
7.2.1 Envigo Company Details
7.2.2 Envigo Business Overview
7.2.3 Envigo Animal Models Used in Tests Introduction
7.2.4 Envigo Revenue in Animal Models Used in Tests Business (2020-2025)
7.2.5 Envigo Recent Development
7.3 Taconic Biosciences
7.3.1 Taconic Biosciences Company Details
7.3.2 Taconic Biosciences Business Overview
7.3.3 Taconic Biosciences Animal Models Used in Tests Introduction
7.3.4 Taconic Biosciences Revenue in Animal Models Used in Tests Business (2020-2025)
7.3.5 Taconic Biosciences Recent Development
7.4 Jackson Laboratory
7.4.1 Jackson Laboratory Company Details
7.4.2 Jackson Laboratory Business Overview
7.4.3 Jackson Laboratory Animal Models Used in Tests Introduction
7.4.4 Jackson Laboratory Revenue in Animal Models Used in Tests Business (2020-2025)
7.4.5 Jackson Laboratory Recent Development
7.5 Crown Biosciences
7.5.1 Crown Biosciences Company Details
7.5.2 Crown Biosciences Business Overview
7.5.3 Crown Biosciences Animal Models Used in Tests Introduction
7.5.4 Crown Biosciences Revenue in Animal Models Used in Tests Business (2020-2025)
7.5.5 Crown Biosciences Recent Development
7.6 Shanghai SLAC
7.6.1 Shanghai SLAC Company Details
7.6.2 Shanghai SLAC Business Overview
7.6.3 Shanghai SLAC Animal Models Used in Tests Introduction
7.6.4 Shanghai SLAC Revenue in Animal Models Used in Tests Business (2020-2025)
7.6.5 Shanghai SLAC Recent Development
7.7 Shangghai Modelorg
7.7.1 Shangghai Modelorg Company Details
7.7.2 Shangghai Modelorg Business Overview
7.7.3 Shangghai Modelorg Animal Models Used in Tests Introduction
7.7.4 Shangghai Modelorg Revenue in Animal Models Used in Tests Business (2020-2025)
7.7.5 Shangghai Modelorg Recent Development
7.8 GenOway
7.8.1 GenOway Company Details
7.8.2 GenOway Business Overview
7.8.3 GenOway Animal Models Used in Tests Introduction
7.8.4 GenOway Revenue in Animal Models Used in Tests Business (2020-2025)
7.8.5 GenOway Recent Development
7.9 Syngene International
7.9.1 Syngene International Company Details
7.9.2 Syngene International Business Overview
7.9.3 Syngene International Animal Models Used in Tests Introduction
7.9.4 Syngene International Revenue in Animal Models Used in Tests Business (2020-2025)
7.9.5 Syngene International Recent Development
7.10 Psychogenics
7.10.1 Psychogenics Company Details
7.10.2 Psychogenics Business Overview
7.10.3 Psychogenics Animal Models Used in Tests Introduction
7.10.4 Psychogenics Revenue in Animal Models Used in Tests Business (2020-2025)
7.10.5 Psychogenics Recent Development
7.11 Pharmaron
7.11.1 Pharmaron Company Details
7.11.2 Pharmaron Business Overview
7.11.3 Pharmaron Animal Models Used in Tests Introduction
7.11.4 Pharmaron Revenue in Animal Models Used in Tests Business (2020-2025)
7.11.5 Pharmaron Recent Development
7.12 Pharmalegacy
7.12.1 Pharmalegacy Company Details
7.12.2 Pharmalegacy Business Overview
7.12.3 Pharmalegacy Animal Models Used in Tests Introduction
7.12.4 Pharmalegacy Revenue in Animal Models Used in Tests Business (2020-2025)
7.12.5 Pharmalegacy Recent Development
7.13 Vitalstar Biotechnology
7.13.1 Vitalstar Biotechnology Company Details
7.13.2 Vitalstar Biotechnology Business Overview
7.13.3 Vitalstar Biotechnology Animal Models Used in Tests Introduction
7.13.4 Vitalstar Biotechnology Revenue in Animal Models Used in Tests Business (2020-2025)
7.13.5 Vitalstar Biotechnology Recent Development
7.14 JANVIER LABS
7.14.1 JANVIER LABS Company Details
7.14.2 JANVIER LABS Business Overview
7.14.3 JANVIER LABS Animal Models Used in Tests Introduction
7.14.4 JANVIER LABS Revenue in Animal Models Used in Tests Business (2020-2025)
7.14.5 JANVIER LABS Recent Development
8 Animal Models Used in Tests Market Dynamics
8.1 Animal Models Used in Tests Industry Trends
8.2 Animal Models Used in Tests Market Drivers
8.3 Animal Models Used in Tests Market Challenges
8.4 Animal Models Used in Tests Market Restraints
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global Animal Models Used in Tests market is projected to grow from US$ 2744 million in 2025 to US$ 3946 million by 2032, at a CAGR of 5.4% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published Date: 2026-03-09
Pages: 136
USD 4900.00
(Single User License)
The global Animal Models Used in Tests market size was US$ 2744 million in 2025 and is forecast to reach a readjusted size of US$ 3946 million by 2032 with a CAGR of 5.4% during the forecast period 2026-2032.
Published Date: 2026-03-09
Pages: 93
USD 4250.00
(Single User License)
The global market for Animal Models Used in Tests was estimated to be worth US$ 2744 million in 2025 and is projected to reach US$ 3946 million, growing at a CAGR of 5.4% from 2026 to 2032.
Published Date: 2026-03-05
Pages: 114
USD 3950.00
(Single User License)
The global Animal Models Used in Tests market was valued at US$ 2744 million in 2025 and is anticipated to reach US$ 3946 million by 2032, at a CAGR of 5.4% from 2026 to 2032.
Published Date: 2026-03-05
Pages: 111
USD 2900.00
(Single User License)
The global Animal Models Used in Tests market is projected to grow from US$ 2617 million in 2024 to US$ 3763 million by 2031, at a CAGR of 5.4% (2025-2031), driven by critical product segments and diverse end‑use applications.
Published Date: 2025-10-23
Pages: 131
USD 4900.00
(Single User License)
The global market for Animal Models Used in Tests was estimated to be worth US$ 2617 million in 2024 and is forecast to a readjusted size of US$ 3763 million by 2031 with a CAGR of 5.4% during the forecast period 2025-2031.
Published Date: 2025-05-24
Pages: 115
USD 3950.00
(Single User License)
The global Animal Models Used in Tests market is projected to grow from US$ 2744 million in 2025 to US$ 3763 million by 2031, at a Compound Annual Growth Rate (CAGR) of 5.4% during the forecast period.
Published Date: 2025-05-24
Pages: 132
USD 4900.00
(Single User License)
The global market for Animal Models Used in Tests was valued at US$ 2617 million in the year 2024 and is projected to reach a revised size of US$ 3763 million by 2031, growing at a CAGR of 5.4% during the forecast period.
Published Date: 2025-05-24
Pages: 84
USD 2900.00
(Single User License)
The global market for Animal Models Used in Tests was estimated to be worth US$ 2617 million in 2024 and is forecast to a readjusted size of US$ 3763 million by 2031 with a CAGR of 5.4% during the forecast period 2025-2031.
Published Date: 2025-02-19
Pages: 88
USD 3950.00
(Single User License)
Animal model is a living, non-human animal used during the research and investigation of human disease, for the purpose of better understanding the disease without the added risk of harming an actual human being during the process.
Published Date: 2024-04-19
Pages: 95
USD 4900.00
(Single User License)
The global Animal Models Used in Tests market is projected to grow from US$ 2744 million in 2025 to US$ 3946 million by 2032, at a CAGR of 5.4% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published: 2026-03-09
Pages: 136
The global Animal Models Used in Tests market size was US$ 2744 million in 2025 and is forecast to reach a readjusted size of US$ 3946 million by 2032 with a CAGR of 5.4% during the forecast period 2026-2032.
Published: 2026-03-09
Pages: 93
The global market for Animal Models Used in Tests was estimated to be worth US$ 2744 million in 2025 and is projected to reach US$ 3946 million, growing at a CAGR of 5.4% from 2026 to 2032.
Published: 2026-03-05
Pages: 114
The global Animal Models Used in Tests market was valued at US$ 2744 million in 2025 and is anticipated to reach US$ 3946 million by 2032, at a CAGR of 5.4% from 2026 to 2032.
Published: 2026-03-05
Pages: 111
The global Animal Models Used in Tests market is projected to grow from US$ 2617 million in 2024 to US$ 3763 million by 2031, at a CAGR of 5.4% (2025-2031), driven by critical product segments and diverse end‑use applications.
Published: 2025-10-23
Pages: 131
The global market for Animal Models Used in Tests was estimated to be worth US$ 2617 million in 2024 and is forecast to a readjusted size of US$ 3763 million by 2031 with a CAGR of 5.4% during the forecast period 2025-2031.
Published: 2025-05-24
Pages: 115
The global Animal Models Used in Tests market is projected to grow from US$ 2744 million in 2025 to US$ 3763 million by 2031, at a Compound Annual Growth Rate (CAGR) of 5.4% during the forecast period.
Published: 2025-05-24
Pages: 132
The global market for Animal Models Used in Tests was valued at US$ 2617 million in the year 2024 and is projected to reach a revised size of US$ 3763 million by 2031, growing at a CAGR of 5.4% during the forecast period.
Published: 2025-05-24
Pages: 84
The global market for Animal Models Used in Tests was estimated to be worth US$ 2617 million in 2024 and is forecast to a readjusted size of US$ 3763 million by 2031 with a CAGR of 5.4% during the forecast period 2025-2031.
Published: 2025-02-19
Pages: 88
Animal model is a living, non-human animal used during the research and investigation of human disease, for the purpose of better understanding the disease without the added risk of harming an actual human being during the process.
Published: 2024-04-19
Pages: 95
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
WHY THIS REPORT
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now